Tonix Pharmaceuticals Holding Corp (TNXP)
R&D Expenses
$19.42M
Quarterly · Period ending: · USD
TNXP R&D Expenses
Latest reported$19.42Mperiod ending
Latest reported$19.42Mperiod ending
TNXP Quarterly R&D Expenses ($0.00 → $19.42M)
Quarterly R&D Expenses
High-resolution chart · PNG
TNXP r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 19,417,000 | |
| 18,213,000 | |
| 16,941,000 | |
| 9,289,000 | |
| 10,820,000 | |
| 7,436,000 | |
| 8,297,000 | |
| 9,114,000 | |
| 9,698,000 | |
| 12,863,000 | |
| 17,120,000 | |
| 21,050,000 | |
| 21,976,000 | |
| 26,511,000 | |
| 24,674,000 | |
| 22,201,000 | |
| 16,579,000 | |
| 18,422,000 | |
| 22,296,000 | |
| 13,082,000 | |
| 18,133,000 | |
| 15,327,000 | |
| 12,097,000 | |
| 8,813,000 | |
| 10,571,000 | |
| 4,676,000 | |
| 5,690,000 | |
| 5,052,000 | |
| 3,554,000 | |
| 3,896,000 | |
| 5,057,000 | |
| 3,264,000 | |
| 4,067,000 | |
| 5,170,000 | |
| 3,634,000 | |
| 3,908,000 | |
| 2,806,000 | |
| 2,994,000 | |
| 4,879,000 | |
| 5,466,000 | |
| 7,516,000 | |
| 10,671,000 | |
| 9,490,000 | |
| 10,314,000 | |
| 8,871,000 | |
| 6,829,000 | |
| 5,775,000 | |
| 5,217,000 | |
| 4,075,000 | |
| 3,550,000 | |
| 1,328,000 | |
| 1,636,827 | |
| 943,995 | |
| 740,629 | |
| 699,749 | |
| 658,143 | |
| 827,788 | |
| 397,628 | |
| 1,158,167 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |